Cargando…
Mesenchymal stem cell as salvage treatment for refractory chronic GVHD
Refractory chronic GVHD (cGVHD) is an important complication after allogeneic hematopoietic SCT and is prognostic of poor outcome. MSCs are involved in tissue repair and modulating immune responses in vitro and in vivo. From April 2005 to October 2008, 19 patients with refractory cGVHD were treated...
Autores principales: | Weng, J Y, Du, X, Geng, S X, Peng, Y W, Wang, Z, Lu, Z S, Wu, S J, Luo, C W, Guo, R, Ling, W, Deng, C X, Liao, P J, Xiang, A P |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3035976/ https://www.ncbi.nlm.nih.gov/pubmed/20818445 http://dx.doi.org/10.1038/bmt.2010.195 |
Ejemplares similares
-
CAFs secreted exosomes promote metastasis and chemotherapy resistance by enhancing cell stemness and epithelial-mesenchymal transition in colorectal cancer
por: Hu, J. L., et al.
Publicado: (2019) -
Fecal microbiota transplantation combined with ruxolitinib as a salvage treatment for intestinal steroid-refractory acute GVHD
por: Liu, Yin, et al.
Publicado: (2022) -
The promotion of the transformation of quiescent gastric cancer stem cells by IL-17 and the underlying mechanisms
por: Jiang, Y-X, et al.
Publicado: (2017) -
Autophagy prevents irradiation injury and maintains stemness through decreasing ROS generation in mesenchymal stem cells
por: Hou, J, et al.
Publicado: (2013) -
Salvaged single-unit cord blood transplantation for 26 patients with
hematologic malignancies not in remission
por: Yao, W., et al.
Publicado: (2015)